Phase 3 Trial Confirms Sarilumab Improves Polymyalgia Rheumatica Outcomes
Vibeke Strand, MD Credit: PRIME Education New phase 3 data supported the effectiveness of sarilumab 200 mg every…
HHS cites scientific justification for canceling mRNA vaccine work
WASHINGTON — Federal health officials are citing an extensive list of studies purported to document harms caused by…